GATA2 deficiency increases the risk of which complications?

GATA2 deficiency is a genetic condition that plays a crucial role in hematopoiesis and immune system function. Individuals with GATA2 deficiency are at increased risk for a variety of complications due to their impaired immune response and problems with blood cell development.

One of the significant risks associated with GATA2 deficiency is the development of myelodysplastic syndromes (MDS) and an increased susceptibility to certain viral infections, including those caused by human papillomavirus (HPV). This connection arises because GATA2 is important for the normal function of hematopoietic stem cells, and its deficiency can lead to abnormalities in blood cell production, resulting in a compromised immune system. Therefore, patients may have a higher chance of developing malignancies such as MDS due to altered cell maturation and proliferation.

The increased risk of HPV complications arises from the impaired immune surveillance that typically helps control viral infections. GATA2 deficiency can lead to a higher incidence of warts or even cervical dysplasia associated with HPV infection because the immune system is less capable of managing these viral challenges. Hence, the link between GATA2 deficiency, HPV-related conditions, and myelodysplasia is well-established in clinical observations of affected individuals.

The other options listed,